| Kristen J Townley, MD | |
|
2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804-7423 | |
| (406) 721-5600 | |
| (406) 329-7192 |
| Full Name | Kristen J Townley |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 2835 Fort Missoula Rd Bldg 3, Missoula, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891749446 | NPI | - | NPPES |
| 0143702 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 10834 (Montana) | Primary |
| 207N00000X | Dermatology | 10834 (Montana) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Montana Clinic Pc | 2466365002 | 40 |
News Archive
A study in mice has shown that large numbers of vascular endothelial cells can be generated from human amniotic fluid-derived cells.
The mass use of antibiotics has caused a rise of bacterial resistance to these drugs that is threatening to destroy the power of these life saving drugs.
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.
Adding the right prebiotic to the diets of pediatric patients with intestinal failure could replace intravenous feeding, says a new University of Illinois study.
The Food and Drug Administration (FDA) ensures that high-risk medical devices, such as implantable cardioverter-defibrillators and pacemakers, are safe and effective through its premarket approval (PMA) pathway, during which manufacturers must collect preclinical and clinical data before the device is approved.
› Verified 4 days ago
| Entity Name | Western Montana Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253182 PECOS PAC ID: 2466365002 Enrollment ID: O20031110000361 |
News Archive
A study in mice has shown that large numbers of vascular endothelial cells can be generated from human amniotic fluid-derived cells.
The mass use of antibiotics has caused a rise of bacterial resistance to these drugs that is threatening to destroy the power of these life saving drugs.
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.
Adding the right prebiotic to the diets of pediatric patients with intestinal failure could replace intravenous feeding, says a new University of Illinois study.
The Food and Drug Administration (FDA) ensures that high-risk medical devices, such as implantable cardioverter-defibrillators and pacemakers, are safe and effective through its premarket approval (PMA) pathway, during which manufacturers must collect preclinical and clinical data before the device is approved.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen J Townley, MD Po Box 7609, Missoula, MT 59807-7609 Ph: (406) 721-5600 | Kristen J Townley, MD 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804-7423 Ph: (406) 721-5600 |
News Archive
A study in mice has shown that large numbers of vascular endothelial cells can be generated from human amniotic fluid-derived cells.
The mass use of antibiotics has caused a rise of bacterial resistance to these drugs that is threatening to destroy the power of these life saving drugs.
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.
Adding the right prebiotic to the diets of pediatric patients with intestinal failure could replace intravenous feeding, says a new University of Illinois study.
The Food and Drug Administration (FDA) ensures that high-risk medical devices, such as implantable cardioverter-defibrillators and pacemakers, are safe and effective through its premarket approval (PMA) pathway, during which manufacturers must collect preclinical and clinical data before the device is approved.
› Verified 4 days ago
Dr. Kevin Mcmullen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1821 South Ave W Ste 402, Missoula, MT 59801 Phone: 406-543-8512 Fax: 406-541-8513 | |
Jacob James Inda, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 | |
Charlotte L Kutsch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd, Ste 302, Missoula, MT 59804 Phone: 406-721-3497 | |
Shannon Kaye Foster, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 | |
Andrew R. Tegeder, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 Fax: 406-329-7192 | |
Jessica Kelly Sempler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 Fax: 406-329-7192 | |
Mr. Lance Randall Hinther, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2825 Fort Missoula Road, Suite 201, Missoula, MT 59804 Phone: 406-549-7556 Fax: 406-728-1868 |